We protect

the genome.

DNA damage is the cause of cancer and a major driver of aging

Mutations drive cells toward dividing rapidly and uncontrollably, leading to oncogenesis

As we age, DNA damage leads to genome instability, epigenetic entropy, and a loss of cellular identity

Cellular dysregulation causes systemic inflammation, accelerating disease progression

Permanence Bio is developing therapeutics that act at the root of disease

Preventing DNA damage would lead to the prevention of cancer, treatments for patients with acute ophthalmological and renal illnesses, and cures for patients with numerous genetic diseases

Protecting the genome can save the lives of those exposed to radiation and chemical hazards

Our approach incorporates a high-throughput screening platform that drives artificial intelligence for the discovery of genome-stabilizing therapies

Our team is deeply passionate about the mission

We aspire to make a meaningful change in the world by changing how we think about disease: prioritizing the prevention of core drivers of illness

We are advised by many of the world’s experts in cancer prevention, medicinal chemistry, and longevity

Permanence Bio logo, with "Permanence Bio" framed by an ouroboros in the shape of an infinity symbol.